1-oxy-quinolin-7-ylamine | 99512-71-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 1-oxy-quinolin-7-ylamine
• CAS: 99512-71-7
• 化学式: C₉H₈N₂O
• 分子量: 160.175
• InChiKey: GWPNMEINYMOKRR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.06
• 重原子数：
  12.0
• 可旋转键数：
  0.0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  52.96
• 氢给体数：
  1.0
• 氢受体数：
  2.0

反应信息

• 作为产物：
  描述：

  trans-3-(2,4-dinitrophenyl)prop-2-enal 在 sodium hydroxide 、 bakers' yeast 作用下， 以 乙醇 、 水 为溶剂， 反应 1.0h， 以51%的产率得到1-oxy-quinolin-7-ylamine
  参考文献：
  名称：

  Baker's yeast reduction of nitroarenes in NaOH media 5. Reductive cyclization of o-nitrocinnamaldehydes

  摘要：

  Reduction of 2-nitrocinnamaldehydes or 4-(2'-nitrophenyl)-3-buten-2-one by bakers' yeast has been found to be cyclized in NaOH media, resulting in the formation of quinolines via cyclized N-oxides. (C) 1997 Elsevier Science Ltd.

  DOI：

  10.1016/s0040-4039(97)00978-7

文献信息

• FLUOROPHORE CHELATED LANTHANIDE LUMINESCENT PROBES WITH IMPROVED QUANTUM EFFICIENCY
  申请人：Mustaev Arkady

  公开号：US20130202536A1

  公开（公告）日：2013-08-08

  The invention relates to novel luminescent compositions of matter containing a fluorophore, synthetic methods for making the compositions, macromolecular conjugates of the compositions, and the use of the compositions in various methods of detection. The invention also provides kits containing the compositions and their conjugates for use in the methods of detection.

  这项发明涉及含有荧光物质的新型发光组合物，制备这些组合物的合成方法，这些组合物的高分子共轭物，以及在各种检测方法中使用这些组合物的用途。该发明还提供了包含这些组合物及其共轭物的试剂盒，用于上述检测方法。
• [EN] 7-AMINO ALKYLIDENYL-HETEROCYCLIC QUINOLONES AND NAPHTHYRIDONES<br/>[FR] NAPHTYRIDONES ET QUINOLONES 7-AMINO ALKYLIDENYL-HETEROCYCLIQUES
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2005033108A1

  公开（公告）日：2005-04-14

  The present invention relates to compounds having a structure according to Formula I wherein n, m, z, R, R2, R3, R4, R5, R6, A, E, X, Y a and b are as defined above; or an optical isomer, diastereomer or enantiomer thereof; a pharmaceutically acceptable salt, hydrate, or prodrug thereof.

  本发明涉及具有如下式I所示结构的化合物，其中n、m、z、R、R2、R3、R4、R5、R6、A、E、X、Y、a和b如上所定义；或其光学异构体、对映异构体或对映体；以及其药学上可接受的盐、水合物或前药。
• [EN] METAL CHELATORS FOR IMAGING, THERAPEUTICS, AND BIOANALYSIS<br/>[FR] CHÉLATEURS MÉTALLIQUES POUR L'IMAGERIE, LA THÉRAPIE, ET LA BIOANALYSE
  申请人：UNIV ILLINOIS

  公开号：WO2018048879A1

  公开（公告）日：2018-03-15

  A variety of compounds are provided capable of chelating a metal, in particular a lanthanide such as Eu(III) and Tb(III). Luminescent complexes of the compound and a metal ion are also provided, in particular luminescent metal complexes are provided containing a lanthanide such as Eu(III) or Tb(III) and a compound described herein. In some aspects, the luminescent complexes are capable of exhibiting bright emissions with high quantum yields. Methods of making the compound are provided. Methods of using the compounds and luminescent complexes are also provided, for example for imaging and therapeutic applications.

  提供了一系列化合物，能够螯合金属，特别是镧系金属如Eu(III)和Tb(III)。还提供了该化合物与金属离子形成的发光配合物，特别是提供了含有镧系金属如Eu(III)或Tb(III)和本文所述化合物的发光金属配合物。在某些方面，这些发光配合物能够展现出具有高量子产率的明亮发射。提供了制备该化合物的方法。还提供了使用这些化合物和发光配合物的方法，例如用于成像和治疗应用。
• Bicyclic androgen and progesterone receptor modulator compounds and methods
  申请人：Zhi Lin

  公开号：US20050288350A1

  公开（公告）日：2005-12-29

  The present invention is directed to compounds, pharmaceutical compositions, and methods for modulating processes mediated by AR and PR. More particularly, the invention relates to nonsteroidal compounds and compositions that are high affinity, high specificity agonists, partial agonists (i.e., partial activators and/or tissue-specific activators) and antagonists for AR and PR. Also provided are methods of making such compounds and pharmaceutical compositions, as well as critical intermediates used in their synthesis.

  本发明涉及化合物、制药组合物和调节由AR和PR介导的过程的方法。更具体地，本发明涉及非甾体化合物和组合物，它们是高亲和力、高特异性的AR和PR激动剂、部分激动剂（即部分激活剂和/或组织特异性激活剂）和拮抗剂。还提供了制备这些化合物和制药组合物的方法，以及在它们的合成中使用的关键中间体。
• Quinolone and naphthyridine antibacterial agents containing an alpha-amino acid in the side chain of the 7-substituent
  申请人：WARNER-LAMBERT COMPANY

  公开号：EP0304087A2

  公开（公告）日：1989-02-22

  Novel quinolone and naphthyridine antibacterial agents of the formula I are herein described having improved in vivo activity both orally and subcutaneously where the 7-side chain of such compounds contain an a-amino acid; also described are its corresponding optical isomers, methods of preparation as well as pharmaceutical useful intreating infectious diseases.

  本文描述了式 I 的新型喹诺酮类和萘啶类抗菌剂，其口服和皮下注射活性均有所提高。 所述的新型喹诺酮类和萘啶类抗菌剂具有更好的口服和皮下注射活性，其中此类化合物的 7 侧链含有 a-氨基酸；还描述了其相应的光学异构体、制备方法以及治疗传染性疾病的药物用途。